Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0250
-0.0350 (-1.70%)
NASDAQ · Last Trade: Oct 1st, 10:54 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors